Compound Library
Metabolic Peptides
GLP-1/GIP/glucagon agonists, mitochondrial peptides, and metabolic regulators engineered for fat loss, insulin sensitivity, and substrate flexibility.
23 compounds
- 5-Amino-1MQMost fat-loss compounds in this space work by hammering appetite (GLP-1s), cranking the CNS (stimulants), or uncoupling mitochondria outright (DNP). 5-Amino-1MQFat Loss 5/10Oral8–12wk
- AdipotideWhy Adipotide Earns Its Niche Adipotide (FTPP) is the most mechanistically elegant fat-loss peptide in the underground market. Unlike GLP-1s, which work throuFat Loss 7/10SubQ2–4wk
- AOD-9604AOD-9604 occupies a specific niche in the fat-loss toolkit: it's the lipolytic tail of human growth hormone — residues 176–191 with an added N-terminal tyrosineFat Loss 4/10SubQ8–16wk
- BAM15BAM15 — The Mitochondrial Uncoupler That Doesn't Try to Kill You BAM15 is the compound physique-focused users reach for when GLP-1s plateau, when DNP is off tFat Loss 7/10Oral4–8wk
- CagrilintideWhy Cagrilintide Earned Its Reputation Cagrilintide is a long-acting amylin analog that hits appetite through a completely different pathway than the GLP-1s eFat Loss 8/10SubQ12–32wk
- CagriSemaBlendWhy CagriSema Is Worth Paying Attention To CagriSema is the first peptide combo that has credibly out-performed semaglutide monotherapy in a head-to-head phasFat Loss 10/10SubQ16–68wk
- HGH Fragment 176-191HGH Fragment 176-191 (sold clinically as AOD-9604) is the C-terminal lipolytic tail of human growth hormone — the fat-burning signal without the IGF-1, the wateFat Loss 4/10SubQ8–16wk
- InsulinInsulin is the most anabolic hormone in the human body — and in the bodybuilding and looksmaxxing community, it's used not for glucose control but as a post-worMuscle 7/10SubQ (abdominal, 4–6mm 31G slin pin)4–8wk
- L-CarnitineL-carnitine has quietly become one of the most useful adjuncts in the cutting and recomp toolkit — not because it's flashy, but because it does one thing almostEndurance 5/10IM8–16wk
- LevothyroxineWhy Levothyroxine Still Has a Place in a Cutting Toolkit Levothyroxine (T4) is the synthetic version of the thyroid prohormone your body already makes, and itFat Loss 5/10Oral6–10wk
- LiothyronineLiothyronine — T3, sold as Cytomel or Tiromel — is the active thyroid hormone itself, and it remains one of the most aggressive fat-loss tools in the bodybuildiFat Loss 8/10Oral4–8wk
- MazdutideWhy Mazdutide Earned Its Reputation Mazdutide is the first GLP-1/glucagon dual receptor agonist to reach approval, and it's the compound the physique and lookFat Loss 9/10SubQ16–48wk
- MetforminMetformin is the quietest workhorse in the physique-and-longevity toolkit. It's cheap, prescription-legal, and has more high-quality outcome data behind it thanFat Loss 3/10Oral (XR preferred for GI tolerance)4–52wk
- MirabegronMirabegron: The Cleanest BAT Activator Available Mirabegron occupies a niche that stimulants and thyroid analogs cannot fill. As a selective β3-adrenergic recFat Loss 4/10Oral4–16wk
- MOTS-cWhy MOTS-c Earned Its Spot in the Stack MOTS-c is one of the more interesting peptides to come out of the last decade of mitochondrial biology — a 16-amino-acEndurance 7/10SubQ4–6wk
- OleoylethanolamideWhy OEA Earned Its Spot in the Cutting Toolkit Oleoylethanolamide is the endogenous lipid your small intestine already makes every time dietary fat hits the dFat Loss 5/10Oral8–16wk
- OrforglipronOrforglipron is the first orally bioavailable non-peptide GLP-1 receptor agonist to reach Phase 3, and for the physique and looksmaxxing community it solves theFat Loss 7/10Oral16–72wk
- RetatrutideWhy Retatrutide Is the Most Talked-About Fat Loss Compound of the Decade Retatrutide is the first triple agonist to hit the grey market — a single peptide thaFat Loss 10/10SubQ12–24wk
- SemaglutideWhy Semaglutide Became the Cutting Tool Semaglutide rewrote what a cut looks like. A once-weekly shot that quiets "food noise," crushes appetite, and producesFat Loss 9/10SubQ12–68wk
- SLU-PP-332SLU-PP-332 is the first small molecule to credibly deliver on the "exercise in a vial" promise — a pan-ERR agonist that switches on the same mitochondrial and fEndurance 8/10SubQ4–12wk
- SurvodutideSurvodutide (BI 456906) is the most mechanistically interesting fat-loss peptide currently circulating grey-market — a dual GLP-1 / glucagon receptor agonist thFat Loss 9/10SubQ24–48wk
- TesofensineWhy Tesofensine Gets Attention Tesofensine is the appetite-suppressing small molecule that keeps surfacing in cutting and looksmaxxing circles because the PhaFat Loss 9/10Oral8–12wk
- TirzepatideTirzepatide is the most effective fat-loss pharmaceutical ever brought to market, and the physique community figured that out roughly ten minutes after the SURMFat Loss 10/10SubQ8–24wk